Patent · US Expired

Phosphoinositol-glycan-peptide with insulin-like action

US5624903A · kind A · utility

23Cited by

2References

7Claims

0Family size

Assignee

Heochst Aktiengesellschaft · DE

Inventors

Gunter Muller · Frankfurt am Main, DE
Dominique Tripier · Solms, DE
Stefan Mullner · Langenfeld, DE

Key dates

Filing date	Dec 23, 1994
Grant date	Apr 29, 1997
Priority date	—
Expiry date	Dec 23, 2014

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Phosphoinositol-glycan-peptide with insulin-like action Phosphoinositol-glycan-peptides obtainable by cleavage of adenosine 3',5'-cyclic monophosphate-binding protein, which contain glucosamine, galactose, mannose, inositol, phosphoric acid, ethanolamine and a peptide with the sequence Asx-Cys-Tyr, the preparation and use thereof for the treatment of diabetes mellitus and non-insulin-dependent diabetes are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.